Drugs / Cefotetan
Cefotetan
also known as
Cefotan · CEFOTETAN DISODIUM · Cefotetan disodium salt · Cefotetan sodium · ICI 156,834 · NSC-760045 · Yamatetan · YM-09330
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | CEFOTAN | — | 1991-11-25 | fda.gov ↗ |
| Approved | US (FDA) | CEFOTAN | — | 1985-12-27 | fda.gov ↗ |
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04726046 | Apr 2014 → Aug 2015 | cholecystitis | Chonbuk National University Hospital | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT07318584 | Mar 2026 → Feb 2028 expected | escherichia coli discitis | Oregon Health and Science University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT01220661 | Oct 2010 → Dec 2011 | — | National Cancer Center, Korea | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00090272 | Apr 2002 → Mar 2005 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT02099240 Comparator | Mar 2014 → Nov 2018 | osteomyelitis | University of Louisville | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00186082 Comparator | Sep 2003 → Jun 2006 | puerperal infection | Stanford University | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cefotetan | “Cefotetan” NCT02099240 ↗ |
| Known as | Cefotan | ChEMBL registry synonym — accepted as the source's own label CHEMBL474579 ↗ |
| Known as | CEFOTETAN DISODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL474579 ↗ |
| Known as | Cefotetan disodium salt | ChEMBL registry synonym — accepted as the source's own label CHEMBL474579 ↗ |
| Known as | Cefotetan sodium | ChEMBL registry synonym — accepted as the source's own label CHEMBL474579 ↗ |
| Known as | ICI 156,834 | ChEMBL registry synonym — accepted as the source's own label CHEMBL474579 ↗ |
| Known as | NSC-760045 | ChEMBL registry synonym — accepted as the source's own label CHEMBL474579 ↗ |
| Known as | Yamatetan | ChEMBL registry synonym — accepted as the source's own label CHEMBL474579 ↗ |
| Known as | YM-09330 | ChEMBL registry synonym — accepted as the source's own label CHEMBL474579 ↗ |
| Modality | Small molecule | — CHEMBL474579 ↗ |
| Route | Intravenous | “1 g intravenously” NCT00186082 ↗ |